Participation

Traders Fair Singapore Returns for an Unforgettable Financial Event

Retrieved on: 
Friday, February 23, 2024
Participation, Software, Tourism

Singapore , Feb. 23, 2024 (GLOBE NEWSWIRE) -- Traders Fair, one of the largest and most prestigious financial events globally, is set to make a triumphant return to Singapore.

Key Points: 
  • Singapore , Feb. 23, 2024 (GLOBE NEWSWIRE) -- Traders Fair, one of the largest and most prestigious financial events globally, is set to make a triumphant return to Singapore.
  • Traders Fair Singapore is scheduled to take place on 02/02/2024 at Marina Bay Sans Convention Center.
  • Why Attend Traders Fair Singapore:
    Traders Fair Singapore offers a unique platform for traders, investors, and financial enthusiasts to:
    • Gain valuable knowledge and insights from industry experts.
  • To secure your spot and learn more about the event agenda, exhibitors, speakers, and special offers, please visit Traders Fair Singapore website .

Ocean Capital Calls on Shareholders to Demand Accountability at UBS-Managed Puerto Rico Closed-End Funds

Retrieved on: 
Tuesday, March 5, 2024
Professional Services, Finance, Schedule 13D, Opinion, Recommendation, Participation, Partial, Judgement, UBS, BLUE, CARD, Annual general meeting, OCEAN, Fund, Report, Security (finance), TFF

In addition to electing Ocean Capital’s nominees, Ocean Capital has submitted a business proposal to terminate the investment advisory agreements with UBS at both of these upcoming annual meetings.

Key Points: 
  • In addition to electing Ocean Capital’s nominees, Ocean Capital has submitted a business proposal to terminate the investment advisory agreements with UBS at both of these upcoming annual meetings.
  • Ocean Capital will continue to do everything in its power to compel UBS and its affiliates to respect the will of shareholders.
  • VISIT WWW.IMPROVEUBSPRFUNDS.COM TO LEARN MORE ABOUT OCEAN CAPITAL’S CAMPAIGNS FOR VALUE-ENHANCING CHANGE AT THE FUNDS.
  • 2 The nine Funds include: Tax-Free Fixed Income Fund for Puerto Rico Residents, Inc. (“Fund I”), Tax-Free Fixed Income Fund II for Puerto Rico Residents, Inc. (“Fund II”), Tax-Free Fixed Income Fund III for Puerto Rico Residents, Inc. (“Fund III”), Tax-Free Fixed Income Fund IV for Puerto Rico Residents, Inc. (“Fund IV”), Tax-Free Fixed Income Fund V for Puerto Rico Residents, Inc. (“Fund V”), Puerto Rico Residents Tax-Free Fund, Inc. (“PRITF I”), Puerto Rico Residents Tax-Free Fund IV, Inc (“PRITF IV”), Puerto Rico Residents Tax-Free Fund VI, Inc. (“PRITF VI”) and Tax-Free Fund for Puerto Rico Residents (“TFF I”).

Strategic Organizing Center Issues Statement on ISS Recommendation

Retrieved on: 
Friday, March 1, 2024
Retail, Professional Services, Food, Beverage, Finance, Annual general meeting, Proxy, Starbucks, Participation, BLUE, Nature, Government, Workers United, ISS, Strategic Organizing Center, Annual, SOC, SBUX, Management

The Strategic Organizing Center (the “SOC”), a shareholder of Starbucks Corporation (Nasdaq: SBUX) (“Starbucks” or the “Company”), today commented on the recent report published by Institutional Shareholder Services Inc. (“ISS”) in relation to Starbucks’ upcoming Annual Meeting of Shareholders (the “Annual Meeting”).

Key Points: 
  • The Strategic Organizing Center (the “SOC”), a shareholder of Starbucks Corporation (Nasdaq: SBUX) (“Starbucks” or the “Company”), today commented on the recent report published by Institutional Shareholder Services Inc. (“ISS”) in relation to Starbucks’ upcoming Annual Meeting of Shareholders (the “Annual Meeting”).
  • “While ISS acknowledged the validity of a number of our arguments in its report, we disagree with the view that board change is not currently needed at Starbucks.
  • ISS also concurs that shareholders should be concerned by Starbucks’ share price performance since unionization efforts began.
  • Further, we agree with ISS that the recent announcement of Starbucks and Workers United committing to a path forward is meaningful progress.

FREYR Battery Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, February 29, 2024
Batteries, Other Manufacturing, Alternative Energy, EV, Electric Vehicles, Energy, Automotive, Technology, Manufacturing, Electrode, Battery, Participation, New York Stock Exchange, Investment, Quasi-solid, NMC, LFP, Central European, Automation, Map, Casting, DOE, Kilowatt-hour, Research, Software

FREYR Battery, Inc. (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, today reported financial results for the fourth quarter and full year of 2023.

Key Points: 
  • FREYR Battery, Inc. (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, today reported financial results for the fourth quarter and full year of 2023.
  • FREYR expects to commence production of functional battery cells for customer samples using the full automation of the CQP in H1 2024.
  • FREYR reported net loss attributable to stockholders for the fourth quarter of 2023 of $(24.2) million, or $(0.17) per diluted share compared to net income for the fourth quarter 2022 of $25.3 million or $0.20 per diluted share.
  • A presentation will be held today, February 29, 2024, at 8:30 am Eastern Standard Time (2:30 pm Central European Time) to discuss financial results for the fourth quarter and full year 2023.

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 20, 2024
Biotechnology, General Health, Pharmaceutical, Health, Toxicity, Growth, Ovarian cancer, Radiopharmaceutical, Patient, Anal cancer, Bicycle, McKinsey & Company, Head, Cervical cancer, EV, Neoplasm, ATM, Therapy, Food and Drug Administration, TNBC, Net, Former, CMC, Thromboxane A2, Immune system, NSCLC, MUC, Peripheral neuropathy, SunOpta, Safety, Ovary, Participation, Knowledge, Novartis, Lazard, BRC, FDA, Cancer, Food, Pembrolizumab, Government, ADC, Brentuximab vedotin, CD137, Pharmaceutical industry

Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided recent corporate updates.

Key Points: 
  • Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided recent corporate updates.
  • We continue to demonstrate our ability to develop highly differentiated, precision-guided therapeutics that may offer greater tolerability and lead to enhanced benefit for patients,” said Kevin Lee, Ph.D., CEO of Bicycle Therapeutics.
  • Validating the company’s Bicycle® Radio Conjugates (BRC™) pipeline and partner for success, with updates expected from its wholly owned BRC program by mid-2024.
  • Advancing the company’s Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) immune-oncology pipeline through innovative partnerships.

Strategic Organizing Center Releases Investor Presentation Highlighting Why Board Change is Needed Now in Order to Brew a Better Starbucks

Retrieved on: 
Tuesday, February 20, 2024
Retail, Professional Services, Food, Beverage, Finance, Public policy, Proxy, Starbucks, Multimedia, Participation, National Labor Relations Board, BLUE, Nature, Government, Ministry of Labour, Annual general meeting, Strategic Organizing Center, SOC, SBUX, Management

The Strategic Organizing Center (the “SOC”), a shareholder of Starbucks Corporation (Nasdaq: SBUX) (“Starbucks” or the “Company”), today announced the release of an investor presentation detailing the urgent need for change at the Company.

Key Points: 
  • The Strategic Organizing Center (the “SOC”), a shareholder of Starbucks Corporation (Nasdaq: SBUX) (“Starbucks” or the “Company”), today announced the release of an investor presentation detailing the urgent need for change at the Company.
  • The presentation – titled “Brew a Better Starbucks” – is available at www.BrewABetterStarbucks.com .
  • View the full release here: https://www.businesswire.com/news/home/20240220437846/en/
    The SOC stated: “Starbucks is an iconic company that has lost its way.
  • Most importantly, these nominees possess expertise sorely lacking on the current Board.

Community-Based Research: A New Frontier of Sites and the Benefits for Clinical Trials -- Part 1, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, March 7, 2024
Participation, SVP, Physician, Drug development, Commercial, Patient, Clinical trial, Research, Pharmaceutical industry

TORONTO, March 7, 2024 /PRNewswire-PRWeb/ -- Participant representation in research can be improved by offering clinical trials in community healthcare settings, known as community-based research, leading to better access to new care options for patients that have been historically not included in clinical trials.

Key Points: 
  • Attendees will get an introduction to the Community-Based Research Network and what "community-based research" means, with a focus on access and inclusion.
  • The featured speakers will share how community-based research differs from other research models, and how sponsors can embrace community-based research and the value these sites provide to clinical trials.
  • Attendees will learn about the benefits of community-based research, and the various differences to consider when working with sites integrated into community health systems.
  • The speakers will also discuss factors sponsors should consider when selecting community-based research sites, including types of clinical trials that are successful within these sites.

Crown Castle Co-Founder Ted B. Miller Issues Statement on Crown Castle's Rewrite of Cooperation Agreement with Elliott

Retrieved on: 
Monday, March 4, 2024
Boot, Participation, Crown Castle, ANY, Common stock, WHEN, Common, Tenant, Annual general meeting, GOLD, Security (finance), WRCB, UPON, Corporation, AS, Investment

HOUSTON, March 4, 2024 /PRNewswire/ -- Ted B. Miller, co-founder of Crown Castle Inc. (NYSE: CCI) ("Crown Castle" or the "Company") and his investment vehicle Boots Capital Management, LLC ("Boots Capital") today issued the following statement:

Key Points: 
  • Similarly, statements that describe the Participants' (as defined below) objectives, plans or goals are forward-looking.
  • There can be no assurance that any idea or assumption herein is, or will be proven, correct.
  • BOOTS CAPITAL STRONGLY ADVISES ALL SHAREHOLDERS OF CROWN CASTLE TO READ THE PRELIMINARY PROXY STATEMENT, ANY AMENDMENTS OR SUPPLEMENTS TO SUCH PROXY STATEMENT, THE DEFINITIVE PROXY STATEMENT, AS WELL AS PROXY MATERIALS FILED BY CROWN CASTLE AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.

Crown Castle Co-Founder Ted B. Miller Files Lawsuit to Invalidate Crown Castle's Unlawful Cooperation Agreement with Elliott

Retrieved on: 
Wednesday, February 28, 2024
Boot, Participation, Crown Castle, ANY, Common stock, WHEN, Cardinal Health, Common, Tenant, Annual general meeting, GOLD, Security (finance), WRCB, UPON, Corporation, AS, Investment

HOUSTON, Feb. 28, 2024 /PRNewswire/ -- Ted B. Miller, co-founder of Crown Castle Inc. (NYSE: CCI) ("Crown Castle" or the "Company") and his investment vehicle Boots Capital Management, LLC ("Boots Capital") today filed a complaint in the Court of Chancery of the State of Delaware (the "Court") seeking to invalidate the cooperation agreement between Crown Castle's Board of Directors (the "Board") and Elliott Investment Management, L.P. (together with its affiliates, "Elliott") announced on December 20, 2023. Under the terms of the cooperation agreement, Elliott and the Company appointed two new directors, Jason Genrich, Partner at Elliott, and Sunit Patel, Chief Financial Officer of Ibotta Inc. (collectively, the "Elliott Directors"), to the Board. Elliott received substantial governance rights without the customary provision that it be required to maintain an equity ownership position in the Company.1

Key Points: 
  • Similarly, statements that describe the Participants' (as defined below) objectives, plans or goals are forward-looking.
  • There can be no assurance that any idea or assumption herein is, or will be proven, correct.
  • IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.
  • 1 For example, Pinterest, Inc. entered into a cooperation agreement with Elliott on December 6, 2022, and Cardinal Health, Inc. entered into a cooperation agreement with Elliott on September 5, 2022, which each required that Elliott maintain an equity ownership threshold of 4.3% and 2.25%, respectively.

Notice of Ericsson's Annual General Meeting 2024

Retrieved on: 
Wednesday, February 28, 2024
Transfer, Person, Travel, Greenhouse, Nasdaq Stockholm, Annual report, F5, Inc., Cisco, Peer group, Corporation, Bank statement, Equity swap, IBM, Ethics, Participation, Compensation, Section 31, Swedish, Social Security, Treasury, Companies Act, Remuneration, Guideline, Chapter Four, Executive, Woman, Committee, Motorola Solutions, Calendar, ESG, LTV, Carbon, Business travel, Employment, Carbon accounting, GHG, Acquisition, KC, Air travel, Note, TSR, CGI Inc., Investor AB, AGM, Annual, Security (finance)

Information about the outcome of the performance criteria will be provided no later than in the annual report for the financial year 2026.

Key Points: 
  • Information about the outcome of the performance criteria will be provided no later than in the annual report for the financial year 2026.
  • The new shares shall be subscribed for during the period as from April 25, 2024, up to and including May 2, 2024.
  • The Company has decided to implement one other share-related compensation program for 2024: the Key Contribution Plan 2024 ("KC Plan 2024").
  • The new shares shall be subscribed for during the period as from April 25, 2024, up to and including May 2, 2024.